ARSA (Search Result) Help

Search Condition

Quick Search

Available Fields

Field	Query Formats
Primary Accession Number	Search all wordsPrimaryAccessionNumber:(AB999999 AND AB999998 ...) Search any wordsPrimaryAccessionNumber:(AB999999 OR AB999999 ...) Regexp queryPrimaryAccessionNumber:/regexp/
Accession Number	Search all wordsAccessionNumber:(AB999999 AND AB888888 ...) Search any wordsAccessionNumber:(AB999999 OR AB888888 ...) Regexp queryAccessionNumber:/regexp/
Division	Search any divisionsDivision:(HUM OR PRI ...)
Sequence Length	Search rangingSequenceLength:[450 TO 500]
Molecular Type	Search any molecular typesMolecularType:(mRNA OR DNA ...)
Molecular Form	Search any molecular formsMolecularForm:(circular OR linear)
Date	Search rangingDate:[20090601 TO 20090701]
Definition	Search all wordsDefinition:(partial AND cds ...) Search any wordsDefinition:(partial OR cds ...) Regexp queryDefinition:/regexp/ Search exactly matchDefinition:"partial cds"
Comment	Search all wordsComment:(sequencing AND project ...) Search any wordsComment:(sequencing OR project ...) Regexp queryComment:/regexp/ Search exactly matchComment:"sequencing project"
Keyword	Search all wordsKeyword:(HTC AND HTC_FLI ...) Search any wordsKeyword:(HTC OR HTC_FLI ...) Regexp queryKeyword:/regexp/ Search exactly matchKeyword:"oligo capping"
Organism	Search all wordsOrganism:(Homo AND sapiens ...) Search any wordsOrganism:(Homo OR sapiens ...) Regexp queryOrganism:/regexp/ Search exactly matchOrganism:"Homo sapiens"
Lineage	Search all wordsLineage:(Eukaryota AND Metazoa ...) Search any wordsLineage:(Eukaryota OR Metazoa ...) Regexp queryLineage:/regexp/
Reference Author	Search all wordsReferenceAuthor:(Mishima AND Shizuoka ...) Search any wordsReferenceAuthor:(Mishima OR Shizuoka ...) Regexp queryReferenceAuthor:/regexp/ Search exactly matchReferenceAuthor:"Mishima,H."
Reference Title	Search all wordsReferenceTitle:(expressed AND liver ...) Search any wordsReferenceTitle:(expressed OR liver ...) Regexp queryReferenceTitle:/regexp/ Search exactly matchReferenceTitle:"expressed in human liver"
Reference Journal	Search all wordsReferenceJournal:(30-NOV-2008 AND Hanako ...) Search any wordsReferenceJournal:(30-NOV-2008 OR Hanako ...) Regexp queryReferenceJournal:/regexp/ Search exactly matchReferenceJournal:"Hanako Mishima"
Reference PubmedID	Search all wordsReferencePubmedID:(1111111 AND 1111112 ...) Search any wordsReferencePubmedID:(1111111 OR 1111112 ...) Regexp queryReferencePubmedID:/regexp/ Search rangingReferencePubmedID:[1111110 TO 1111119]
Feature	Search all wordsFeature:(GT200015 AND gt11 ...) Search any wordsFeature:(GT200015 OR gt11 ...) Search exactly matchFeature:"gene=\"GAPD\""
Feature Qualifier	Search one feature-qualifierFeatureQualifier:/source \/clone=GT200015/ Search all feature-qualifiersFeatureQualifier:(/source \/clone=GT200015/ AND /CDS \/gene=GAPD/ ...)
All Text	Search with field_name 'AllText'AllText:any_formats

LOCUS	AB000000 450 bp mRNA linear HUM 01-JUN-2009
DEFINITION	Homo sapiens GAPD mRNA for glyceraldehyde-3-phosphate dehydrogenase, partial cds.
ACCESSION	AB999999 AB888888 AB777777
VERSION	AB000000.1
KEYWORDS	HTC; HTC_FLI; oligo capping.
SOURCE	Homo sapiens (human)
ORGANISM	Homo sapiens
	Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
	Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
	Catarrhini; Hominidae; Homo.
REFERENCE	1 (bases 1 to 450)
AUTHORS	Mishima,H. and Shizuoka,T.
TITLE	Direct Submission
JOURNAL	Submitted (30-NOV-2008) to the DDBJ/EMBL/GenBank databases. Contact:Hanako Mishima National Institute of Genetics, DNA Data Bank of Japan; Yata 1111, Mishima, Shizuoka 411-8540, Japan
PUBMED	1111111
REFERENCE	2
AUTHORS	Mishima,H., Shizuoka,T. and Fuji,I.
TITLE	Glyceraldehyde-3-phosphate dehydrogenase expressed in human liver
JOURNAL	Unpublished (2009)
COMMENT	Human cDNA sequencing project.
FEATURES		Location/Qualifiers
source		1..450
source		/chromosome="12"
source		/clone="GT200015"
source		/clone_lib="lambda gt11 human liver cDNA (GeneTech. No.20)"
source		/db_xref="taxon:9606"
source		/map="12p13"
source		/mol_type="mRNA"
source		/organism="Homo sapiens"
source		/tissue_type="liver"
CDS		86..>450
CDS		/codon_start=1
CDS		/gene="GAPD"
CDS		/product="glyceraldehyde-3-phosphate dehydrogenase"
CDS		/protein_id="BAA12345.1"
CDS		/transl_table=1
CDS		/translation="MAKIKIGINGFGRIGRLVARVALQSDDVELVAVNDPFITTDYMT YMFKYDTVHGQWKHHEVKVKDSKTLLFGEKEVTVFGCRNPKEIPWGETSAEFVVEYTG VFTDKDKAVAQLKGGAKKV"
BASE COUNT 102 a 119 c 131 g 98 t
ORIGIN
1 cccacgcgtc cggtcgcatc gcacttgtag ctctcgaccc ccgcatctca tccctcctct
61 cgcttagttc agatcgaaat cgcaaatggc gaagattaag atcgggatca atgggttcgg
121 gaggatcggg aggctcgtgg ccagggtggc cctgcagagc gacgacgtcg agctcgtcgc
181 cgtcaacgac cccttcatca ccaccgacta catgacatac atgttcaagt atgacactgt
241 gcacggccag tggaagcatc atgaggttaa ggtgaaggac tccaagaccc ttctcttcgg
301 tgagaaggag gtcaccgtgt tcggctgcag gaaccctaag gagatcccat ggggtgagac
361 tagcgctgag tttgttgtgg agtacactgg tgttttcact gacaaggaca aggccgttgc
421 tcaacttaag ggtggtgcta agaaggtctg
//

Search Result

Facet

List of Entries

1 - entries / Number of founds: 503342 FlatFile XML Fasta

	PrimaryAccessionNumber	Definition	SequenceLength	MolecularType	Organism
	OF298621	KR 1020210131855-A/3: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	18	RNA	synthetic construct
	OF298626	KR 1020210131855-A/8: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298620	KR 1020210131855-A/2: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298625	KR 1020210131855-A/7: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298630	KR 1020210131855-A/12: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	23	DNA	synthetic construct
	OF756628	KR 1020210131855-A/17: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	415	PRT	synthetic construct
	OF756629	KR 1020210131855-A/19: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	801	PRT	synthetic construct
	OF756630	KR 1020210131855-A/21: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	3972	PRT	synthetic construct
	OF298623	KR 1020210131855-A/5: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298628	KR 1020210131855-A/10: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298622	KR 1020210131855-A/4: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298627	KR 1020210131855-A/9: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298619	KR 1020210131855-A/1: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	19	RNA	synthetic construct
	OF298624	KR 1020210131855-A/6: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	20	RNA	synthetic construct
	OF298629	KR 1020210131855-A/11: A pharmaceutical compositon for treating lung cancer comprising R-point regulatory protein complex as an active ingredient, a screening method for treating lung cancer using the formation of the complex, and a method for diagnosing lung cancer.	23	DNA	synthetic construct
	HW615992	JP 2014168434-A/1: Prediction-inspection method of efficacy of lung cancer treatment and Screening method for lung cancer drug.	25	RNA	synthetic construct
	HZ489212	JP 2016015948-A/10: METHODFOR OBTAINING INFORMATION ON LUNG CANCER, AND MARKERS AND KIT FOR OBTAINING INFORMATION ON LUNG CANCER.	21	DNA	synthetic construct
	HV444573	JP 2011515081-A/7: Method for detecting lung cancer using lung cancer-specific methylation marker gene.	25	DNA	synthetic construct
	HV444581	JP 2011515081-A/15: Method for detecting lung cancer using lung cancer-specific methylation marker gene.	23	DNA	synthetic construct
	DI181555	KR 1020090098677-A/5: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene.	30	DNA	artificial sequences
	DI181563	KR 1020090098677-A/13: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene.	22	DNA	artificial sequences
	DI181571	KR 1020090098677-A/21: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene.	19	DNA	artificial sequences
	DI896030	KR 1020160051475-A/4: Composition and kit for diagnosing lung cancer and method for diagnosis of lung cancer using the same.	138	PRT	synthetic construct
	PE603678	KR 1020220157860-A/1: Method for prognosis of recurrence in patients with lung cancer and pharmaceutical composition for preventing recurrent lung cancer.	211	PRT	synthetic construct
	PE603679	KR 1020220157860-A/3: Method for prognosis of recurrence in patients with lung cancer and pharmaceutical composition for preventing recurrent lung cancer.	351	PRT	synthetic construct
	DI181560	KR 1020090098677-A/10: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene.	30	DNA	artificial sequences
	DI181568	KR 1020090098677-A/18: Method for Detecting Lung Cancer Using Lung Cancer Specific Methylated Marker Gene.	19	DNA	artificial sequences
	HZ489206	JP 2016015948-A/4: METHODFOR OBTAINING INFORMATION ON LUNG CANCER, AND MARKERS AND KIT FOR OBTAINING INFORMATION ON LUNG CANCER.	121	DNA	synthetic construct
	HV444574	JP 2011515081-A/8: Method for detecting lung cancer using lung cancer-specific methylation marker gene.	27	DNA	synthetic construct
	HV444582	JP 2011515081-A/16: Method for detecting lung cancer using lung cancer-specific methylation marker gene.	20	DNA	synthetic construct
Now loading

PAGE TOP